Sarcopenic Obesity: Time to Meet the Challenge
Open accessThe DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Abstract
The prevalence of overweight and obesity has reached epidemic proportions worldwide due to increasingly pervasive obesogenic lifestyle changes. Obesity poses unprecedented individual, social, and multidisciplinary medical challenges by increasing the risk for metabolic diseases, chronic organ failures, and cancer as well as complication rates in the presence of acute disease conditions. Whereas reducing excess adiposity remains the fundamental pathogenic treatment for obese individuals, complex metabolic and lifestyle abnormalities as well as weight reduction therapies per se may also compromise the ability to preserve muscle function and mass, especially when chronic disease co-exists with obesity. Emerging evidence indicates that low muscle mass and quality have a strong negative prognostic impact in obese individuals and may lead to frailty, disability, and increased morbidity and mortality. Awareness of the importance of skeletal muscle maintenance in obesity is however low among clinicians and scientists. The term ‘sarcopenic obesity' has been proposed to identify obesity with low skeletal muscle function and mass, but its utilization is largely limited to the aging patient population, and consensus on its definition and diagnostic criteria remains insufficient. Knowledge on prevalence of sarcopenic obesity in various clinical conditions and patient subgroups, on its clinical impacts in patient risk stratification, and on effective prevention and treatment strategies remain therefore dramatically inadequate. In particular, optimal dietary options and medical nutritional support strategies to preserve muscle mass in obese individuals remain largely undefined. The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) recognize and indicate obesity with altered body composition due to low skeletal muscle function and mass (sarcopenic obesity) as a scientific and clinical priority for researchers and clinicians. ESPEN and EASO therefore call for coordinated action aimed at reaching consensus on its definition, diagnostic criteria, and optimal treatment with particular regard to nutritional therapy. We are convinced that achievement of these goals has a strong potential to reduce the burden of morbidity and mortality in the rapidly increasing obese patient population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consensus statements have emphasized that SO should be understood as a disorder of body composition and function rather than as a simple coexistence of two diagnoses (1, 2).”
From Exercise-based interventions for sarcopenic obesity in middle-aged and older adults: an umbrella review of systematic reviews with pairwise meta-analyses and network meta-analyses (2026) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“cytokines produced by infiltrating cells such as macrophages can cause muscular atrophy by inducing filament protein degradation and apoptosis (21).”
From Sarcopenic obesity: epidemiology, pathophysiology, cardiovascular disease, mortality, and management (2023) · cites this paper as [21]
In the citing paper
“Indeed, there are multiple biological effects of physical activity: promote insulin sensitivity, improve anabolic response to endogenous amino acids, activate skeletal muscle satellites cells and trigger the proliferation and differentiation of them, amplify irisin production, adjust hormonal milieu, increase mitochondrial biogenesis, ameliorate inflammation and reduce oxidative stress (162–164).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [162]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Self-citationThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“…: clustered metabolic de-rangements including systemic and muscle oxidative stress, in fl ammation and insulin resistance may occur in obesity [17 e 20] due to various causes that primarily include a) excess nutrient availability and tissue delivery, particularly saturated fat [28] and…”
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058 · cited 2×
“Reducing excess adiposity remains the fundamental pathogenetic treatment for obese individuals [15,16].”
McClave, S. A., Taylor, B. E., Martindale, R. G., Warren, M. M., Johnson, D. R., Braunschweig, C., McCarthy, M. S., Davanos, E., Rice, T. W., Cresci, G. A., et al. (2016) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115621863 · Cited by 3,982
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Self-citationGlobal burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238 · cited 1×
“Indeed low or declining muscle mass is emerging as a negative prognostic factor associated with higher morbidity and mortality in obese patients with chronic diseases [67 e 69].”
Cited by
Items 201–244 of 244
Schmerzen und nicht medikamentöse Interventionen
Laube, W., & Daase, A. (2023) · Springer eBooks · doi:10.1007/978-3-662-66215-1_2
Liu, C., tao, X., Niu, R., Lü, W., Zeng, X., & Sun, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3635355/v1
Magenballonimplantation – eine Bestandsaufnahme unter Berücksichtigung eigener Erfahrungen
Keßler, R., Glitsch, A., Hübner, B., Gärtner, S., Steveling, A., Patrzyk, M., & Keßler, W. (2023) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2185-7671
Elderly/Masters Athlete (Overview)
Piedade, S. R., Teixeira, R. C., Beck, L. A. D. S., & Ferreira, D. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-33867-0_2
Natalie, M. R., & Santoso, A. H. (2024) · Malahayati Nursing Journal · doi:10.33024/mnj.v6i2.12882
Švab, I., Klemenc–Ketiš, Z., & Homar, V. (2024) · doi:10.18690/um.mf.1.2024
Soares, B. L. D. M., Soares, N. M. D. M., Burgos, M. G. P. D. A., & de Arruda, I. K. G. (2024) · Radiologia Brasileira · doi:10.1590/0100-3984.2024.0026
BIA법에 의한 농촌지역 남성 장년층의 비만도 및 근감소증에 따른 체구성, 형태 및 체력변인에 대한 비교분석 연구
박, 재., 권, 대., & 송, 영. (2024) · 한국체육학회지 · doi:10.23949/kjpe.2024.11.63.6.29
Yang, Q., Ji, W., Guo, J., Fu, H., Li, H., Gao, J., & Hou, C. (2025) · Journal of Clinical Nursing · doi:10.1111/jocn.17755
Choi, S., Kim, M., Soh, Y., & Won, C. W. (2025) · Medicina · doi:10.3390/medicina61111909 · Cited by 2
“Loss of skeletal muscle mass and function generally occurs with aging, and it is often accompanied by an increase in body fat [1].”
Abud, G. F., Ortiz, G. U., Venturini, A. C. R., Travieso, S. G., Fogagnolo, C., Viliod, M. C. D. L., Esteves, G. P., Silva, B. M., da Silva, A. S. R., & de Freitas, E. C. (2025) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000002716 · Cited by 1
Additional file 1 of The prevalence of low muscle mass associated with obesity in the USA
Murdock, D. J., Wu, N., Grimsby, J. S., Calle, R. A., Donahue, S., Glass, D. J., Sleeman, M. W., & Sanchez, R. J. (2024) · Figshare · doi:10.6084/m9.figshare.26556449
Sarcopenic Obesity and Hormones: A Narrative Review
Yu, D., & Zhou, B. (2025) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2025.1312003 · Cited by 1
Santos, T. F. D., Maciel, G. R., & Bandeira, F. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113069 · Cited by 1
Kloypan, C., Promsrisuk, T., Suwannakul, B., Kaewjoho, C., & Srithawong, A. (2026) · Diseases · doi:10.3390/diseases14010018
“The multisystem effects of metabolic syndrome, such as vascular stiffness, chronic low-grade inflammation, and disrupted muscle vascular crosstalk, may further exacerbate mobility limitations in older adult [27,49].”
Aydogan, O. O., Oksuzoglu, A. D., & Turanlı, B. (2026) · Metabolites · doi:10.3390/metabo16020095
“Increased pro-inflammatory cytokines, intramyocellular accumulation of lipids, and macrophage infiltration enhance the muscular atrophy and lipotoxicity mechanisms [22,24,25].”
Shao, H., Wang, Y., Park, Y.-K., & Jung, H. W. (2026) · Nutrients · doi:10.3390/nu18030429
“This creates a lipotoxic microenvironment within skeletal muscle, accompanied by the over-accumulation of mitochondrial ROS (mtROS) and activation of inflammatory signaling, which inhibits protein synthesis and enhances protein degradation [8–11].”
Lee, D., Heo, D., Ryu, J., Kim, K. S., & Kim, M. (2026) · Research Square · doi:10.21203/rs.3.rs-8852127/v1
The role of CXCL10 in high‐fat diet–induced skeletal muscle inflammation and atrophy
Liyuan, A., Hirata, Y., Inoue, T., Sugawara, K., & Ogawa, W. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70270 · Cited by 1
Conte, S. L., Bufano, A., Cevenini, G., Paolo, B., Castagna, M. G., & Alessandra, C. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106398
Wang, Y., Li, H., Li, Y., Kong, W., & Li, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062677
“Ectopic fat infiltration reduces muscle strength, exacerbating vulnerability to falls, fractures, and mobility impairments [18,19].”
Chen, X., Liu, C., Fu, W., Liu, Y., Lu, B., & Tang, H. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71703
Bellicha, A. (2018) · theses.fr (ABES) · doi:10.70675/8fbdc52fz2e73z42d9zb6d9zf95020e4018e · Cited by 1
Sarcopenia and physical performance among older adults with increased body mass index and falls
Hashim, N. N. A., Mat, S., Myint, P. K., Delibegović, M., Kioh, S. H., Kamaruzzaman, S. B., Hairi, N. N., Khoo, S., & Tan, M. P. (2026) · Scientific Reports · doi:10.1038/s41598-026-49574-0
“Sarcopenic obesity exacerbates frailty by synergistically incorporating the detrimental consequences of muscular atrophy and excessive adiposity (e.g. metabolic disorder, chronic inflammation, cardiovascular complications, negative psychological impact) 24–27 .”
Godziuk, K., Tilley, S., LaValley, M. P., Nevitt, M. C., Lewis, C. E., Torner, J. C., & Neogi, T. (2026) · Arthritis Care & Research · doi:10.1002/acr.80066 · Cited by 1
“24,25 Metabolic impairments can lead to skeletal muscle dysfunction, 37 through systemic in fl ammation, mitochondrial dysfunction, anabolic resistance, and muscle remodeling, 38 resulting in alterations in muscle strength and function and loss of muscle mass. 39 Similar to our fi ndings, both high…”
Tabakchi, O. E., Дамировна, М. Д., Bodryagina, E. S., Черемина, Н. А., Odintsova, A. K., & Abdulganieva, D. (2026) · Medical alphabet · doi:10.33667/2078-5631-2026-5-54-60
Construction and validation of a machine learning model to predict the sarcopenic obesity population
Zhang, M., Dong, D., Liu, C., Liu, Y., & Zhang, Z. D. (2026) · Medicine · doi:10.1097/md.0000000000049142
“[4,5] 8] Therefore, the urgent need to develop a novel and easily accessible prediction model for the early screening of SO is of great importance for the whole society.”
Zhang, X., Shen, Y., Wang, B., & Chen, J. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1786526
“Second, the significance of NRS-2002 in a predominantly obese population (mean BMI > 31 kg/m 2 ) is consistent with the “obesity paradox” and the prevalence of sarcopenic obesity (20).”
Booranasuksakul, U., Siervo, M., Singhato, A., Rueangsri, N., Samrit, T., Suriyawongpaisal, W., & Prasertsri, P. (2026) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph23060815
“Sarcopenia and obesity share common underlying mechanisms, including chronic low-grade inflammation, insulin resistance, oxidative stress, and hormonal alterations [6].”
Chen, S. H., Chou, C., Weng, S., Chen, J., & Shen, F. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70379
“Abdominal obesity, characterized by visceral fat accumulation, contributes to systemic in fl ammation and insulin resistance, both of which are key drivers of muscle catabolism 10, 11 .”
Song, J., Gao, J.-F., Yan, Y.-Y., Zhong, L., Wang, X., Mou, X., & Yu, X.-P. (2026) · Medicine · doi:10.1097/md.0000000000049534
“[5,23,25,26,30,34] In this context, PhA in the nonag-ricultural group may reflect a more complex combination of tissue composition, metabolic burden, and cellular status, which could partly reduce the independent contribution of SMI in the fully adjusted model.”
Frigerio, F., & Donini, L. M. (2026) · Endocrinology · doi:10.1007/978-3-030-71067-5_23-1
Gracioto, P. G. A., de Oliveira, J. C. M., & Oliveira, C. R. (2026) · Research Society and Development · doi:10.33448/rsd-v15i7.51444
Krinitskii, D. V., Bashirov, S. R., Аржаник, М. Б., Саприна, Т. В., Prokonich, D. A., & Bashirova, A. S. (2026) · Issues of Reconstructive and Plastic Surgery · doi:10.52581/1814-1471/97/10
Balasubaramaniam, V., Scobie, M., O’Kane, M. P. M., Graham, Y., Robertson, A. G., & Mahawar, K. K. (2026) · Nutrients · doi:10.3390/nu18162643
“Reviews of sarcopenic obesity indicate that this combination of increased fat mass and reduced muscle function is linked to adverse clinical outcomes and necessitates integrated nutritional and physical activity strategies [41,54].”
InfluentialAra-Gimeno, S., Gómez‐Bruton, A., Moradell, A., Lozano‐Berges, G., Fanlo, M. J. P., Sánchez‐Luengo, M., Irún, P., Matute-Llorente, Á., Lanas, Á., González‐Agüero, A., et al. (2026) · Obesity Surgery · doi:10.1007/s11695-026-08890-0 · Cited by 1
“Importantly, emerging evidence indicates that low muscle mass and quality in individuals with obesity are associated with worse clinical outcomes, including frailty, disability, and increased morbidity and mortality [ 4 , 5 ].”
El-Oueslati, H., Youssef, L., Manuel, R. F. J., Boucher, L., Tannou, T., Brodeur, C., Andriamampionona, F., Kergoat, M., & Aubertin‐Leheudre, M. (2026) · medRxiv · doi:10.64898/2026.09.06.26359363
Jiang, T., Wang, X., 姚旭通, Xia, J., & Liang, J. (2026) · Metabolism · doi:10.1016/j.metabol.2026.156787 · Cited by 1
Eren, F. A., Can, B., Can, B., & SARGIN, M. (2026) · Topics in Clinical Nutrition · doi:10.1097/tin.0000000000000454
Aljawini, N., Habib, S. S., & Al-Regaiey, K. (2026) · Nutrients · doi:10.3390/nu18213531
Metadata
- Authors
- Barazzoni, R., Bischoff, S., Boirie, Y., Busetto, L., Cederholm, T., Dicker, D., Toplak, H., Van Gossum, A., Yumuk, V., & Vettor, R.
- Affiliations
- University of Trieste (IT)
- University of Hohenheim (DE)
- University of Padua (IT)
- Uppsala University (SE)
- Tel Aviv University (IL)
- Medical University of Graz (AT)
- Istanbul University-Cerrahpaşa (TR)
- ORCID
- Venue
- Obesity Facts
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 11
- Issue
- 4
- Pages
- 294-305
- ISSN
- 1662-4025 (ISSN-L)
- 1662-4033
- PMC
- PMC6189532
- OpenAlex
- W2883874811
- Cited by
- 244
- References
- 92
- Citations by year
- 2026: 33 · 2025: 26 · 2024: 31 · 2023: 46 · 2022: 39 · 2021: 37 · 2020: 18 · 2019: 11 · 2018: 3
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Obesity Facts (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc-nd)
- KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, obesity, skeletal muscle mass, muscle function, frailty, body composition, diagnostic criteria, nutritional therapy, weight loss, chronic comorbidities
- MeSH terms
- Body Composition, Diet, Humans, Life Style, Obesity, Risk Factors, Prevalence, Muscle, Skeletal, Adiposity, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.